5Yokosuka O, Omata M, lmazeki F, et al. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology, 1985, 5:728-734.
6Nevens F, Main J, Honkoop P, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.Gastroenterology, 1997, 113 : 1258-1263.
7Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med, 1998, 339:61-68.
8Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology, 1998, 27 : 1670-1677.
9Fu L, Cheng YC. Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC(3TC)resistance. Biochem Pharmacol, 1998, 55:1567-1572.
10Wright TL, Lau JY. Clinical aspects of hepatitis B virus infection. Lancet, 1993, 342:1340-1344.
